SCHEMBL30366133

SCHEMBL30366133

Cc1cc(Cl)cnc1C1=CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM1 Q13255 10/20 0.49
GRM5 P41594 9/20 0.49
CNR1 P21554 2/20 0.47
PDK4 Q16654 1/20 0.46
CYP11B2 P19099 1/20 0.46
TNK2 Q07912 1/20 0.46
CDK9 P50750 2/20 0.45
GABRP O00591 1/20 0.44
GABRD O14764 1/20 0.44
GABRA1 P14867 1/20 0.44
GABRB1 P18505 1/20 0.44
GABRG2 P18507 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
GABRA2 P47869 1/20 0.44
GABRB2 P47870 1/20 0.44
GABRA4 P48169 1/20 0.44
GABRE P78334 1/20 0.44
GABRA6 Q16445 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30899649 1.00 GRM1 (0.49) GRM1GRM5CNR1PDK4CYP11B2
SCHEMBL31583898 0.90 GRM1 (0.55) GRM1GRM5CNR1PDK4CYP11B2
SCHEMBL20135287 0.90 GRM1 (0.52) GRM1GRM5PDK4CYP11B2TNK2
SCHEMBL74150 0.88 TNK2 (0.49) GRM1GRM5CNR1PDK4CYP11B2
SCHEMBL15168000 0.87 TNK2 (0.50) GRM1GRM5PDK4CYP11B2TNK2
SCHEMBL15167800 0.87 GRM1 (0.49) GRM1GRM5PDK4CYP11B2TNK2
SCHEMBL25237973 0.85 GRM1 (0.49) GRM1GRM5PDK4CYP11B2TNK2
SCHEMBL31533241 0.85 GRM1 (0.49) GRM1GRM5PDK4CYP11B2TNK2
SCHEMBL25723290 0.84 GRM1 (0.47) GRM1GRM5PDK4CYP11B2TNK2
SCHEMBL30456775 0.84 GRM1 (0.47) GRM1GRM5PDK4CYP11B2TNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405051-A1 PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. Hoffmann-La Roche AG (CH) 2024-07-31 EP disclosed
WO-2023046806-A1 PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2023-03-30 WO disclosed